Skip to content
New: free dose calculator with 14 peptide presets. No signup.
Peptides Academy

Healing & Tissue-Repair Peptides

Peptides studied for tendon, ligament, muscle, and gut repair — BPC-157, TB-500, and related regenerative agents.

Healing & Body-Protection Peptides (6)

Frequently Asked Questions

What is the difference between BPC-157 and TB-500?
They work through different mechanisms and are often combined. BPC-157 modulates the NO system, upregulates growth factor receptors (VEGFR2, FGFR), and promotes angiogenesis — it excels at tendon, ligament, and GI healing in preclinical models. TB-500 (Thymosin Beta-4 fragment) sequesters G-actin to promote cell migration and cytoskeletal remodeling — it addresses the cell-migration component of wound healing. Together, they cover complementary aspects of the repair process.
Do healing peptides work for old injuries or only acute ones?
Most preclinical evidence is in acute injury models. Whether BPC-157 or TB-500 can remodel chronic scar tissue or reverse established tendinopathy is less established. Practitioner reports suggest benefit for chronic conditions, but the biological rationale is weaker — acute healing involves active cellular processes that peptides can amplify, while chronic injuries involve mature scar tissue that may require physical disruption (e.g., PRP, shockwave therapy) before peptides can meaningfully contribute.
Should healing peptides be injected near the injury site?
Local injection near the target tissue provides higher concentration at the injury site and is preferred by most practitioners for musculoskeletal injuries. However, BPC-157 has demonstrated systemic effects in animal models (healing at distant sites from the injection), suggesting subcutaneous injection anywhere may still deliver benefit. For gut-targeted healing, oral BPC-157 is the preferred route since it delivers the peptide directly to the GI mucosa.

Related Product Categories

Browse All peptide Products

Search

Search across products, blog posts, wiki articles, and more.